Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.

Videos

Dr. Mikhail on Ongoing Trials in Multiple Myeloma

Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discusses ongoing clinical trials for patients with myeloma.

Current studies are looking at stem cell transplants in patients with myeloma. There are a lot of immunomodulatory agents and combinations being looked at, says Mikhail.

Immunotherapy for patients with multiple myeloma is also being scrutinized for its safety concerns, but it appears to show encouraging results in other settings, explains Mikhail.

Sameh Mikhail, MD

Articles

Dr. Mikhail on Ongoing Trials in Multiple Myeloma

Dr. Mikhail on Ongoing Clinical Trials for Patients With Myeloma